The Beta-hCG+Erythropoietin in Acute Stroke (BETAS) Study | Zendy

Steven C. Cramer | Zendy; Camille Fitzpatrick | Zendy; Michael Warren | Zendy; Michael D. Hill | Zendy; David M. Brown | Zendy; Laura Whitaker | Zendy; Karla J. Ryckborst | Zendy; L. Plon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Beta-hCG+Erythropoietin in Acute Stroke (BETAS) Study

Author(s) -

Steven C. Cramer,

Camille Fitzpatrick,

Michael Warren,

Michael D. Hill,

David M. Brown,

Laura Whitaker,

Karla J. Ryckborst,

L. Plon

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.574343

Subject(s) - medicine , erythropoietin , stroke (engine) , deep vein , human chorionic gonadotropin , gonadotropin , thrombosis , surgery , hormone , mechanical engineering , engineering

Animal data suggest the use of beta-human chorionic gonadotropin followed by erythropoietin to promote brain repair after stroke. The current study directly translated these results by evaluating safety of this sequential growth factor therapy through a 3-center, single-dose, open-label, noncontrolled, Phase IIa trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research